This Solicitation opportunity from Department Of Defense was posted on July 14, 2026. The submission period has ended. Browse the details below for market research, or find similar active opportunities.
ATENOLOL TABLETS
Contract Overview
Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.
Active Opportunities Like This One
AI Contract Overview
ATENOLOL TABLETS, 25 MG, 100S, under NSN 6505-01-336-6196, are being procured by the Department of Defense through a solicitation issued by the Medical Supply Chain Pharm FSA under solicitation number SPE2DP-26-T-4118. The requirement is for two bulk units, each containing 100 tablets, with delivery required within 20 days after order placement to Fort Stewart, GA, under FOB Destination terms. The item is regulated by the FDA and must comply with stringent packaging and marking standards, including Medical Marking Standard No. 1, which supersedes MIL-STD-129, and preservation and packing in accordance with MIL-STD-2073-1E. Each unit must be sealed in a suitable container to prevent damage, and shipping containers must ensure safe, cost-effective delivery via common carrier, excluding parcel post. The pharmaceutical must meet a non-extendable 36-month shelf life requirement. Multiple manufacturers including Teva Pharmaceuticals, Mylan Pharmaceuticals, and McKesson Corporation are referenced as potential suppliers, with NDC codes provided for traceability. The solicitation applies federal and defense acquisition regulations including FAR 52.246-2 for destination inspection and acceptance, and incorporates specific DFARS clauses addressing safeguarding covered defense information, cybersecurity compliance with NIST SP 800-171, prohibitions on covered telecommunications equipment, trafficking in persons, whistleblower rights, and restrictions on mandatory arbitration. Contractors must comply with the Buy American Act and Berry Amendment, and are required to be registered in SAM with accurate socioeconomic representations, though the acquisition is not a small business set-aside. HUBZone price evaluation preference may apply. All invoices must be processed through WAWF, with payment governed by FAR 52.216-7 and DFARS Appendix F standards. The contractor assumes full responsibility for hazardous material safety, transportation logistics—particularly if shipped by sea—and must flow down applicable clauses to subcontractors. Submission of quotations is due by July 20, 2026, and participation does not obligate the government to award a contract or reimburse costs. System for Award Management registration, data certification requirements under DFARS 252.215-7994, and adherence to all marking, labeling, and cybersecurity protocols are mandatory conditions for eligibility.
General Info
Agency
NAICS
Place of Performance
BLDG 1509 WEST 6TH STREET, FORT STEWART, GA, 31314-5185, USASet-Aside
Timeline
Submission Closed
Organization & Contact Information
Full Description
ATENOLOL TABLETS,25 MG,100S
RP001: DLA PACKAGING REQUIREMENTS FOR PROCUREMENT
RA001: THIS DOCUMENT INCORPORATES TECHNICAL AND/OR QUALITY REQUIREMENTS
(IDENTIFIED BY AN 'R' OR AN 'I' NUMBER) SET FORTH IN FULL TEXT IN THE
DLA MASTER LIST OF TECHNICAL AND QUALITY REQUIREMENTS FOUND ON THE WEB
AT:
http://www.dla.mil/HQ/Acquisition/Offers/eProcurement.aspx http://www.dla.mil/HQ/Acquisition/Offers/eProcurement.aspx
FOR SIMPLIFIED ACQUISITIONS, THE REVISION OF THE MASTER IN EFFECT ON THE SOLICITATION ISSUE DATE OR THE AWARD DATE CONTROLS. FOR LARGE ACQUISITIONS, THE REVISION OF THE MASTER IN EFFECT ON THE RFP ISSUE DATE APPLIES UNLESS A SOLICITATION AMENDMENT INCORPORATES A FOLLOW-ON REVISION, IN WHICH CASE THE AMENDMENT DATE CONTROLS.
This device or drug is regulated by the FDA. Note to Buyers: The contracting official shall send a referral in EBS to the product specialist for confirmation. Please include bidder name and bidder contact information, manufacturer name, manufacturer part number, and item description. 1 BT = 100 TT RS020: Shelf-life requirement RS001 for a TYPE I (CODE Q) item with a shelf life of 36 months (non-extendable) applies to this item.
APPLICABLE TO ALL MEDICAL ACQUISITIONS:
PACKAGING AND PACKING SHALL BE COMMERCIAL AS
SPECIFIED IN THE PROCUREMENT DOCUMENT.
EACH COMPLETE UNIT SHALL BE PROPERLY PACKAGED
IN A SUITABLE SEALED UNIT CONTAINER CAPABLE
OF PROTECTING THE CONTENTS FROM DAMAGE AND/OR
BREAKAGE.
UNITS SHALL BE PACKED IN SUITABLE COMMERCIAL
EXTERIOR (SHIPPING) CONTAINERS (EXPORT WHEN
NECESSARY) WHICH SHALL INSURE ACCEPTANCE AND
SAFE DELIVERY BY COMMON OR OTHER CARRIER, AT
THE LOWEST RATE, TO POINT OF DELIVERY CALLED
FOR IN THE CONTRACT OR ORDER.
MATERIAL MUST BE MARKED IAW MEDICAL MARKING
STANDARD NO. 1. THIS SUPERCEDES ALL REFERENCES
TO MIL-STD-129.
COPIES OF MEDICAL MARKING STANDARD NO. 1
(MMS NO. 1) MAY BE OBTAINED BY CONTACTING DLA
TROOP SUPPORT VIA EMAIL TO fssb@dla.mil. MMS NO. 1 IS ALSO AVAILABLE ONLINE AT: https://www.dla.mil/Logistics-Operations/Packaging/
RD003, COVERED DEFENSE INFORMATION POTENTIALLY APPLIES
SHALL BE MARKED IAW THE LATEST EDITION OF
SPE2DP-26-T-4118
SECTION B
THE MEDICAL MARKING STANDARD NO. 1.
MMS NO. 1 IS AVAILABLE ONLINE AT:
https://www.dla.mil/Logistics-Operations/Packaging/
MCKESSON CORPORATION 34WR5 P/N 463649 TEVA PHARMACEUTICALS USA, INC. 3V8D7 P/N NDC00093-0787-01 MYLAN PHARMACEUTICALS INC 3KJG9 P/N NDC00378-0218-01
DLA issues this document using the DoD authorized unit of issue, please refer to the following URL to determine the corresponding ANSI X12 unit of issue.
https://view.officeapps.live.com/op/view.aspx?src=https%3A%2F%2Fwww.dla.mil%2FPortals%2F104%2FDocuments% 2FDLMS%2FeApplications%2FLogDataAdmin%2FUnitofIssueandPurchaseUnit.xlsx&wdOrigin=BROWSELINK
CLIN PR PRLI UI QUANTITY UNIT PRICE TOTAL PRICE.
0001 7017471545 0001 BT 2.000
NSN/MATERIAL:6505013366196
DELIVERY (IN DAYS):0020
DELIVER FOB: DESTINATION
QTY VARIANCE: PLUS 0% MINUS 0%
INSPECTION POINT: DESTINATION
ACCEPTANCE POINT: DESTINATION
PREP FOR DELIVERY:
PKGING DATA MIL-STD-2073-1E
SPECIAL NSN/Part Number: 6505-01-336-6196 Quantity: 2 BT Purchase Request: 7017471545QTY: 2 Delivery: 20 days ADO
More opportunities from Department Of Defense → MEDICAL SUPPLY CHAIN PHARM FSA
Same awarding agency
Find Active Opportunities Like This
Get AI-powered intelligence on the opportunities still open
Every page of the solicitation package shredded into a compliance breakdown
AI-powered matching based on your capabilities and past performance
Competitor and incumbent history on the requirement
Automated alerts on amendments, Q&A deadlines, and award
Join 650+ contractors already using CLEATUS
